News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Ipsen Aims To Raise €400 Million In IPO
November 23, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Europe
MORE ON THIS TOPIC
Insights
Rewriting the rules of CMV prevention
August 20, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
7 biopharma M&A deals where layoffs followed
August 20, 2026
·
5 min read
·
Angela Gabriel
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 19, 2026
·
1 min read
·
Gabrielle Masson
Manufacturing
Sandoz inks $322M Henlius deal for rights to as many as 10 biosimilars
August 18, 2026
·
2 min read
·
Nick Paul Taylor
